The Insulin Empire | Edward Ongweso Jr. & Athena Sofides thebaffler.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thebaffler.com Daily Mail and Mail on Sunday newspapers.
Novo Nordisk, maker of the blockbuster drugs for diabetes and weight loss respectively, has a market capitalisation of $592.02 billion, making it larger than the entire Danish economy. The company's global CEO talks about its India plans and the need for competition to ramp up innovation in pharma
DIABETES, a chronic ailment stemming from insufficient insulin a hormone that regulates blood glucose levels was once a serious life-threatening condition.
Dhruv Khullar asks if we may someday consider new weight-loss drugs such as Ozempic to be some of the greatest advances in the annals of chronic disease.